Published on The Nathan Kline Institute for Psychiatric Research (https://www.nki.rfmh.org)

Home > Biomarkers of Response to Ketamine in Depression

Biomarkers of Response to Ketamine in Depression [1]

This research study aims to identify markers that predict what patients with depression will improve when treated with ketamine.

Study Length: 
5 visits over about one month
Disorder/Condition: 
Treatment-Resistant Depression
Inclusion Criteria: 

Men or women between the ages of 18 and 65 who have not had a satisfactory response to antidepressant medication. Participants should be in good general health and willing to use birth control if of child bearing potential.

Study Title (brief): 
Biomarkers of Response to Ketamine in Depression
Study Description (brief): 

This research study aims to identify markers that predict what patients with depression will improve when treated with ketamine.

Study Contact: 

Molly Arnold, 845-398-6567, depression@nki.rfmh.org [2]


Source URL: https://www.nki.rfmh.org/content/biomarkers-response-ketamine-depression

Links
[1] https://www.nki.rfmh.org/content/biomarkers-response-ketamine-depression
[2] mailto:depression@nki.rfmh.org